Package 16729-306-10

Brand: azacitidine

Generic: azacitidine
NDC Package

Package Facts

Identity

Package NDC 16729-306-10
Digits Only 1672930610
Product NDC 16729-306
Product ID 16729-306_28604daf-46a3-ef6c-e063-6394a90a4b27
Description

1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (16729-306-10)

Marketing

Marketing Status
Marketed Since 2019-01-09
Brand azacitidine
Generic azacitidine
Sample Package No

Linked Drug Pages (1)

Azacitidine ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "28604daf-46a3-ef6c-e063-6394a90a4b27", "openfda": {"nui": ["N0000000233", "N0000175595"], "upc": ["0316729306102"], "unii": ["M801H13NRU"], "rxcui": ["485246"], "spl_set_id": ["70140e11-33f1-2240-e053-2991aa0a0480"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Accord Healthcare Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (16729-306-10)", "package_ndc": "16729-306-10", "marketing_start_date": "20190109"}], "brand_name": "Azacitidine", "product_id": "16729-306_28604daf-46a3-ef6c-e063-6394a90a4b27", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "16729-306", "generic_name": "Azacitidine", "labeler_name": "Accord Healthcare Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Azacitidine", "active_ingredients": [{"name": "AZACITIDINE", "strength": "100 mg/1"}], "application_number": "ANDA207475", "marketing_category": "ANDA", "marketing_start_date": "20190109", "listing_expiration_date": "20261231"}